Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy W Schacker

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Nature Medicine|June 23, 2009
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNicolas Chomont, Mohamed El-Far, Petronela Ancuta, et al.
The Journal of Infectious Diseases|March 4, 2014
Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV diseaseCarey L Shive, Joseph C Mudd, Nicholas T Funderburg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIVAshma Chakrawarti, Ross T Cromarty, Christopher M Basting, et al.
The Journal of Infectious Diseases|March 11, 2021
Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune ResponseGuoxin Wu, Paul Zuck, Shih Lin Goh, et al.
Pathogens & Immunity|September 27, 2016
A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?Michael M Lederman, Paula M Cannon, Judith S Currier, et al.
Nature|November 24, 2017
Lorenzo-Redondo et al. replyRamon Lorenzo-Redondo, Helen R Fryer, Trevor Bedford, et al.
Nature|January 28, 2016
Persistent HIV-1 replication maintains the tissue reservoir during therapyRamon Lorenzo-Redondo, Helen R Fryer, Trevor Bedford, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Ongoing lymphoid HIV production drives pyroptosis and GLP-1 counter-regulation in ART-suppressed infectionPeter A Crawford, Joshua Rhein, Jeffrey G Chipman, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Pre-treatment Microbiome Diversity and Function is associated with Expansion of Cytotoxic and Regulatory Immune Populations after N-803 treatment in People with HIVAshma Chakrawarti, Ross T Cromarty, Christopher M Basting, et al.
Blood|April 17, 2013
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trialPeter W Hunt, Nancy S Shulman, Timothy L Hayes, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Nature Medicine|June 23, 2009
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNicolas Chomont, Mohamed El-Far, Petronela Ancuta, et al.
The Journal of Infectious Diseases|March 4, 2014
Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV diseaseCarey L Shive, Joseph C Mudd, Nicholas T Funderburg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIVAshma Chakrawarti, Ross T Cromarty, Christopher M Basting, et al.
The Journal of Infectious Diseases|March 11, 2021
Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune ResponseGuoxin Wu, Paul Zuck, Shih Lin Goh, et al.
Pathogens & Immunity|September 27, 2016
A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?Michael M Lederman, Paula M Cannon, Judith S Currier, et al.
Nature|November 24, 2017
Lorenzo-Redondo et al. replyRamon Lorenzo-Redondo, Helen R Fryer, Trevor Bedford, et al.
Nature|January 28, 2016
Persistent HIV-1 replication maintains the tissue reservoir during therapyRamon Lorenzo-Redondo, Helen R Fryer, Trevor Bedford, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Ongoing lymphoid HIV production drives pyroptosis and GLP-1 counter-regulation in ART-suppressed infectionPeter A Crawford, Joshua Rhein, Jeffrey G Chipman, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Pre-treatment Microbiome Diversity and Function is associated with Expansion of Cytotoxic and Regulatory Immune Populations after N-803 treatment in People with HIVAshma Chakrawarti, Ross T Cromarty, Christopher M Basting, et al.
Blood|April 17, 2013
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trialPeter W Hunt, Nancy S Shulman, Timothy L Hayes, et al.
Pageof 9